End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
169.2 EUR | +0.62% | +1.05% | +18.37% |
05-23 | MERCK KGAA : Receives a Buy rating from UBS | ZD |
05-23 | Merck KGaA: acquisition of U.S.-based Mirus Bio | CF |
Sales 2024 * | 21.27B 23.07B 1,812B | Sales 2025 * | 22.54B 24.44B 1,920B | Capitalization | 72.93B 79.1B 6,214B |
---|---|---|---|---|---|
Net income 2024 * | 2.98B 3.23B 254B | Net income 2025 * | 3.5B 3.8B 298B | EV / Sales 2024 * | 3.72 x |
Net Debt 2024 * | 6.28B 6.81B 535B | Net Debt 2025 * | 4.45B 4.82B 379B | EV / Sales 2025 * | 3.43 x |
P/E ratio 2024 * |
24.2
x | P/E ratio 2025 * |
20.5
x | Employees | 62,345 |
Yield 2024 * |
1.33% | Yield 2025 * |
1.44% | Free-Float | 29.71% |
Latest transcript on Merck KGaA
1 day | +0.62% | ||
1 week | +1.05% | ||
Current month | +13.52% | ||
1 month | +12.65% | ||
3 months | +6.52% | ||
6 months | +5.19% | ||
Current year | +18.37% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 12/07/20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 31/07/14 |
Director of Finance/CFO | 53 | 25/04/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 30/04/12 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 31/12/90 |
Date | Price | Change |
---|---|---|
24/05/24 | 167.8 | -0.80% |
23/05/24 | 169.2 | +0.62% |
22/05/24 | 168.1 | +1.42% |
21/05/24 | 165.8 | -0.18% |
20/05/24 | 166 | -0.81% |
End-of-day quote Wiener Boerse, May 22, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.35% | 8.72B | |
-16.83% | 4.79B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock
- MRCK Stock